Interim Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 25, 2021	Sep. 25, 2020
Current assets:
Cash and cash equivalents	$ 1,219,648	$ 1,071,876
Restricted cash	7,604	8,103
Short-term investments	48,277	46,948
Accounts receivable, net of allowance for credit losses of $11,192 and $15,908	275,080	180,340
Contract assets, net of allowance for credit losses of $188 and $0	166,584	161,357
Inventories, net	12,143	25,550
Prepaid expenses and other current assets	43,540	53,022
Total current assets	1,772,876	1,547,196
Long-term investments	54,155	52,149
Property, plant, and equipment, net	538,421	541,963
Operating lease right-of-use assets	71,625	76,515
Intangible assets, net	129,214	152,431
Goodwill	338,385	336,945
Other non-current assets	85,356	91,245
Deferred taxes	145,104	118,881
Total assets	3,135,136	2,917,325
Current liabilities:
Accounts payable	12,187	12,617
Accrued liabilities	255,033	219,974
Income taxes payable	7,902	3,260
Contract liabilities	18,201	15,436
Operating lease liabilities	15,642	15,822
Total current liabilities	308,965	267,109
Non-current contract liabilities	22,142	24,342
Non-current operating lease liabilities	60,967	65,315
Other non-current liabilities	115,248	122,154
Total liabilities	507,322	478,920
Stockholders’ equity:
Retained earnings	2,626,447	2,443,138
Accumulated other comprehensive loss	(5,032)	(10,594)
Total stockholders’ equity – Dolby Laboratories, Inc.	2,621,515	2,432,643
Controlling interest	6,299	5,762
Total stockholders’ equity	2,627,814	2,438,405
Total liabilities and stockholders’ equity	3,135,136	2,917,325
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 65,248,388 shares issued and outstanding at June 25, 2021 and 64,167,725 at September 25, 2020
Stockholders’ equity:
Common stock	59	58
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 36,086,779 shares issued and outstanding at June 25, 2021 and 36,128,720 at September 25, 2020
Stockholders’ equity:
Common stock	$ 41	$ 41